)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Pharvaris
Pharvaris (PHVS) investor relations material
Pharvaris Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary12 Aug, 2026
Executive summary
Advanced deucrictibant IR toward regulatory approval, with NDA under FDA review and MAA validated by EMA in July 2026.
Topline data from pivotal Phase 3 CHAPTER-3 study for deucrictibant XR in HAE prophylaxis expected in 3Q2026.
Enrollment ongoing in pivotal studies for both HAE and AAE-C1INH, including CREAATE and CHAPTER-4.
Expanded Access Program for deucrictibant IR launched in the U.S. for eligible HAE patients.
Promoted Dr. Peng Lu to President, consolidating R&D and commercial leadership.
Financial highlights
Cash and cash equivalents stood at €318 million as of June 30, 2026, up from €292 million at year-end 2025.
R&D expenses were €35.0 million for Q2 2026, compared to €29.6 million in Q2 2025.
G&A expenses were €15.8 million for Q2 2026, up from €10.8 million in Q2 2025.
Net loss for Q2 2026 was €47.8 million, or €0.70 per share, compared to €45.5 million, or €0.83 per share, in Q2 2025.
Closed $132 million underwritten offering in May, extending cash runway into 2028.
Outlook and guidance
Topline data from CHAPTER-3 Phase 3 study expected in Q3 2026.
FDA PDUFA date for deucrictibant IR NDA set for April 23, 2027.
Cash runway extended into 2028, supporting pre-commercial and lifecycle management activities.
What is the PDUFA date for deucrictibant IR NDA?
Detail CHAPTER-3 trial dosage and patient count
Why was Peng Lu promoted to President?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Pharvaris
- Deucrictibant advances in phase III trials for broader angioedema, addressing key unmet needs.PHVS
Status Update - Oral deucrictibant targets broad HAE populations with rapid, sustained efficacy and phase III data due 2026.PHVSThe Citizens JMP Life Sciences Conference
- Deucrictibant shows rapid, durable efficacy and aims for broad HAE market coverage with oral options.PHVSRBC Capital Markets Global Healthcare Conference 2026
- €132M raised, strong clinical data, and dual HAE launches targeted for 2026-2027.PHVSBank of America Global Healthcare Conference 2026
- Oral deucrictibant shows rapid relief and strong prevention for angioedema in late-stage trials.PHVSCorporate presentation
- Phase 3 HAE study enrollment completed; NDA submission and strong liquidity position maintained.PHVSQ4 2025
- Oral deucrictibant shows rapid efficacy and flexibility, targeting both acute and prophy HAE markets.PHVSLeerink Global Healthcare Conference 2026
- Oral therapies for angioedema show strong efficacy, with key launches and filings ahead.PHVSThe Citizens Life Sciences Conference 2026
- Deucrictibant IR 20 mg rapidly relieved HAE attacks with strong efficacy and safety.PHVSStudy Update
Next Pharvaris earnings date
Wells Fargo 21st Annual Healthcare Conference9 Sep, 2026
Pharvaris
Next Pharvaris earnings date
Wells Fargo 21st Annual Healthcare Conference9 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage